Cargando…
Real-world evidence to guide healthcare policies in oncology
Randomized controlled clinical trials (RCTs) in oncology enroll patients who meet strict protocol-specified criteria. Many of these criteria overlap across multiple RCTs. A vast proportion of patients with metastatic cancer do not meet such criteria. Hence, patient populations encountered in clinica...
Autores principales: | Donia, Marco, Hansen, Steen Werner, Svane, Inge Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642046/ https://www.ncbi.nlm.nih.gov/pubmed/31360300 http://dx.doi.org/10.18632/oncotarget.27077 |
Ejemplares similares
-
A perspective on life-cycle health technology assessment and real-world evidence for precision oncology in Canada
por: Regier, Dean A., et al.
Publicado: (2022) -
Real-World Evidence for Equality
por: Johnson, C. Erwin, et al.
Publicado: (2021) -
Factors Affecting Citizen Trust and Public Engagement Relating to the Generation and Use of Real-World Evidence in Healthcare
por: Horgan, Denis, et al.
Publicado: (2022) -
Real-World Evidence in Support of Oncology Product Registration: A Systematic Review of New Drug Application and Biologics License Application Approvals from 2015–2020
por: Arondekar, Bhakti, et al.
Publicado: (2022) -
Real‐World Evidence in EU Medicines Regulation: Enabling Use and Establishing Value
por: Arlett, Peter, et al.
Publicado: (2021)